CD8A and hepatocellular carcinoma: In addition, rNDV-IL2-NP/P had the strongest inhibition of murine hepatoma carcinoma tumors growth, elicited highest degrees of splenocytes CD4+ T and CD8+ T cells, and obviously enhanced animals’ survival rate.